Navigation Links
Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
Date:2/12/2013

CHESTERBROOK, Pa., Feb. 12, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2012 on Tuesday, February 26, 2013 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 10:00 a.m. ET to discuss results and highlights of the fourth quarter and full year 2012.  The presentation slides to be used during the call will be available on the "For Investors" section of the Company's web site under the "Presentations" tab beginning at 10 a.m. ET on Tuesday, February 26, 2013.  A web cast of the conference call and the presentation slides will be available on the "For Investors" section of the Company's web site under the "Events" tab beginning at 10:00 a.m. ET on Tuesday, February 26, 2013.  A question and answer session will follow the presentation. 

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

Mr. Adrian Adams , Chief Executive Officer and President, will host the conference call.Conference call details: Date:

Tuesday, February 26, 2013Time:

10:00 a.m. ETDial-in (U.S.):

866-510-0705Dial-in (International):

617-597-5363Web cast:

http://www.auxilium.com Passcode:

AUXILIUMTo access an audio replay of the call:Access number (U.S.):

888-286-8010 Access number (International):

617-801-6888Replay Passcode #:

92145279About Auxilium
Auxilium is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets Testim® 1% (testosterone gel) for the topi
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Auxilium Announces Appointments to Enhance Leadership Team
2. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
4. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
5. Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
8. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
9. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... York (PRWEB) August 29, 2014 According to ... Orthobiologics Market” the global orthobiologics market was valued at USD ... market worth USD 5,519.9million in 2019at a CAGR of 5.9% ... aged 50 years and above is afflicted by bone and ... by the year 2020. This has and will continue to ...
(Date:8/29/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the six months ended June 30, 2014. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... , Announced top-line results related to the eight ... enrolled in the Phase 2 iDEAL Study evaluating ...
(Date:8/29/2014)... Three Lawrence Livermore researchers have ... Production R&D Award for their research in ... sunlight. , Shared with collaborators from the National ... Nevada, Las Vegas (UNLV), the award recognizes the ... solar-hydrogen production and corrosion processes. , These models ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 A major ... the biotech start-up dense realm of Boston-Cambridge, is gaining ... able investors. James Sherley, the Director of Boston’s Adult ... the local and national visibility of his company an ... 2013. , In addition to a social media marketing ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4
... 150 year expertise in the genetic improvement of animals ... outlook, New Zealand,s biotech industry is well positioned as ... by industry organization NZBIO and New Zealand Trade and ... their capabilities in human health care, animal husbandry, plant ...
... Inc., a subsidiary of Eisai Inc., announced today that it ... food from its employees, more than 5 times as much ... Morphotek, this number equates to over 40 pounds of food ... needy families through collaboration with Philabundance, the area,s largest food ...
... Today at the 2011 BIO International Convention, Scotland, with ... double the economic contribution of its life sciences sector ... country,s rich history of scientific discovery, medical technology, stem ... approach to collaboration across government, academia and industry, Scottish ...
Cached Biology Technology:New Zealand Brings Its Global "Game Plan" to the 2011 BIO International Convention 2Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families 2Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families 3Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO 2Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO 3
(Date:8/28/2014)... PAUL (August 28, 2014) Researchers at the University ... facioscapulohumeral muscular dystrophy (FSHD) to be used for muscle ... of potential therapies for FSHD. , The research is ... Cell Reports . , There is no treatment for ... most common type of muscular dystrophy. FSHD is an ...
(Date:8/28/2014)...  Privacy Advocate and Senior Staff Attorney at the ... the lineup of biometric and mobile commerce experts set ... Summit in Tampa, Florida on ... include Steven Rahman, Director, Technology and Strategy at Samsung, and ... theme of this year,s event is Mobility at the ...
(Date:8/28/2014)... 2014A new method for measuring and imaging how quickly ... researchers better understand how drug abuse affects the brain, ... engineering, and lead to better treatment options for recovering ... of researchers from Stony Brook University in New York, ... published today in The Optical Society,s (OSA) open-access journal ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3
... particularly devastating human kidney disease may be blunted by making ... new research by scientists from North Carolina State University and ... take a major step toward suggesting a beneficial treatment for ... that causes renal failure and death in humans. ...
... built a very simple nanoantenna that directs red and ... is smaller than the wavelength of light. The findings ... this week can lead to optical nanosensors ... or biomolecules. A structure that is smaller than ...
... protein "switch" that instructs cancer cells to produce their own ... that these switches, working from inside the cells, can activate ... linked to cancer. The goal, the scientists said, is to ... to self-destruct while sparing healthy tissue. ...
Cached Biology News:Rogue receptor opens door for rare kidney disease 2Bimetallic nanoantenna separates colors of light 2Protein 'switches' could turn cancer cells into tiny chemotherapy factories 2
... holds 48 x 0.2 ml tubes, or a 48-well ... (470-500 nm) for each well, and a pair of ... nm). This item is a real-time upgrade for owners ... 18 x 32 x 33 cm (W x D ...
... Guava PCA-96 systems provide automated, higher throughput ... of microcentrifuge tubes. This flexible sample format ... screening in basic research, target validation, assay ... smaller cousin, the Guava PCA-96 uses a ...
... novel procedure for the uniform amplification and ... DNA from small samples. This method has ... highly reproducible amplification and labeling procedure for ... Mini Kit module (QIAGEN) and a ULS ...
... KineticScan™ Reader is Cellomics‘ latest ... for Cell-based Screening". The KineticScan ... to do both temporal and ... processes, dynamic distribution and activity ...
Biology Products: